Viewing Study NCT02479373



Ignite Creation Date: 2024-05-06 @ 7:08 AM
Last Modification Date: 2024-10-26 @ 11:45 AM
Study NCT ID: NCT02479373
Status: COMPLETED
Last Update Posted: 2018-04-05
First Post: 2015-05-01

Brief Title: Exercise and Body Composition in Juvenile Idiopathic Arthritis
Sponsor: Johns Hopkins University
Organization: Johns Hopkins University

Study Overview

Official Title: Joint Fitness A Double-Armed Controlled Intervention to Assess the Safety and Effectiveness of Resistance Exercise Training on Muscle Bone Strength Symptoms Quality of Life and Biological Parameters in Children and Young Adults With JIA
Status: COMPLETED
Status Verified Date: 2018-04
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: Joint Fitness
Brief Summary: This research is being done to see if resistance exercise RE is safe and has a positive effect on children and young adults with juvenile idiopathic arthritis JIA

JIA is an inflammatory autoimmune disease that can cause severe impairment and disability JIA can cause bone loss and decreased muscle strength The medications used to treat JIA can also have negative effects on growth and development strength and ability to function RE is performing movements in a slow and controlled fashion ie no speeding up or using force in the lifting and lowering of the weight to lessen force on the joints and tissues This study will be using Ren-Ex exercise equipment to perform RE

Currently the American College of Rheumatology recommends exercise for patients with arthritis This exercise includes range of motion exercise to protect joint mobility as well as low resistance and aerobic exercise AE to protect muscle mass bone health and fitness However a recent study showed no major differences in functionality or quality of life between patients who performed AE and those who did not perform AE There is a need for more data on the impact of RE on children with JIA Children and young adults aged 10 to 21 with juvenile idiopathic arthritis may join
Detailed Description: None

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None
Secondary IDs
Secondary ID Type Domain Link
5R21AR062269-02 NIH None httpsreporternihgovquickSearch5R21AR062269-02